Based on our a priori knowledge of these genes as individual markers of anti-tumor reactivity, we used them to construct single-patient models trained using 80% of the data from MANA- and EBV-/flu-/non-tumor antigen-specific TIL in three melanoma patients. This evidence concerns the gene LINC01194 and melanoma.